The herpes simplex virus type 1 early gene (thymidine kinase) promoter is activated in neurons of brain, but not trigeminal ganglia, of transgenic mice in the absence of viral proteins

Journal of NeuroVirology

Volumn 10, Issue 2, 2004, Pages 116-122

  Loiacono, Christie M ^a   Myers, Robert ^a   Mitchell, William J ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Early; Genes; HSV 1; Human; Transgenic mice; Virus latency

Indexed keywords

BETA GALACTOSIDASE; THYMIDINE KINASE; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL MANIPULATION; CELL SUBPOPULATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE ACTIVATION; GENETIC REGULATION; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HOST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SENSORY GANGLION; SENSORY NERVE CELL; TRANSGENIC MOUSE; TRIGEMINUS GANGLION; VIRUS GENOME; VIRUS REACTIVATION;

ANIMALS; BRAIN; GENES, REPORTER; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; MICE; MICE, TRANSGENIC; NEURONS, AFFERENT; PROMOTER REGIONS (GENETICS); THYMIDINE KINASE; TRANSGENES; TRIGEMINAL GANGLION; VIRUS LATENCY;

HUMAN HERPESVIRUS 1; MUS MUSCULUS; SIMPLEXVIRUS;

EID: 1942518755     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280490279771     Document Type: Article

References (34)

1. Aiba-Masago S, Baba S, Li RY, Shinmura Y, Kosugi I, Arai Y, Nishimura M, Tsutsui Y (1999). Murine cytomegalovirus immediate-early promoter directs astrocyte-specific expression in transgenic mice. Am J Pathol 154: 735-743.
2. Baskar JF, Smith PP, Nilaver G, Jupp RA, Hoffmann S, Peffer NJ, Tenney DJ, Colberg-Poley AM, Ghazal P, Nelson JA (1996). The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol 70: 3207-3214.
3. Caccarno DV, Herman MM, Frankfurter A, Katsetos CD, Collins VP, Rubinstein LJ (1989). An immunohistochemical study of neuropeptides and neuronal cytoskeletal proteins in the neuroepithelial component of a spontaneous murine ovarian teratoma. Am J Pathol 135: 801-813.
4. Chang E, Galle LE, Maggs DJ, Estes DM, Mitchell WJ (2000). Pathogenesis of herpes simplex virus type 1 induced corneal inflammation in perforin-deficient mice. J Virol 74: 11832-11840.
5. Croen KD, Ostrove JM, Dragovic LJ, Smialek JE, Straus SE (1987). Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "antisense" transcript by in situ hybridization. N Engl J Med 317: 1427-1432.
6. Deatly AM, Spivack JG, Lavi E, Fraser NW (1987). RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice. Proc Natl Acad Sci U S A 84: 3204-3208.
7. Deshmane SL, Fraser NW (1989). During latency herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J Virol 63: 943-947.
8. Fraser NW, Valyi-Nagy T (1993). Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation. Microb Pathogen 15: 83-91.
9. Fritschy JM, Brandner S, Aguzzui S, Koedood M, LUscher B, Mitchell PJ (1996). Brain cell type specificity and gliosis-induced activation of the human cytomegalovirus immediate-early promoter in transgenic mice. J Neurosci 16: 2275-2282.
10. Garcia-Blanco MA, Cullen BR (1991). Molecular basis of latency in pathogenic human viruses. Science 254: 815-820.
11. Hill JM, Sedarati F, Javier RT, Wagner EK, Stevens JG (1990). Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 174: 117-125.
12. Hogan B, Beddington R, Costantini F, Lacy E (1994). Manipulating the mouse embryo: a laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
13. Koedad M, Fichtel A, Meier P, Mitchell PJ (1995). Human cytomegalovirus (HCMV) immediate early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J Virol 69: 2194-2207.
14. Loiacono CM, Myers R, Mitchell WJ (2002). Neurons differentially activate the herpes simplex virus type 1 immediate early gene ICP0 and ICP27 promoters in transgenic mice. J Virol 76: 2449-2459.
15. Loiacono CM, Taus NS, Mitchell WJ (2003). The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice. J NeuroVirol 9: 336-345.
16. Maggs D, Chang E, Nasisse M, Mitchell WJ (1998). Persistence of herpes simplex virus type 1 DNA in chronic conjunctival and eyelid lesions of mice. J Virol 72: 9166-9172.
17. Margolis TP, Bloom DC, Dobson AT, Feldman LT, Stevens JG (1993). Decreased reporter gene expression during latent infection with HSV LAT promoter constructs. Virology 197: 585-592.
18. Mcknight SL, Gavis ER, Kingsberry R, Axel R (1981). Analysis of transcriptional regulatory signals of the HSV thymidine kinase gene: identification of an upstream control region. Cell 25: 385-398.
19. Mercer EH, Hoyle GW, Kapur RP, Brinster RL, Palmiter RD (1991). The dopamine β-hydroxylase gene promoter directs expression of E. coli lacZ to sympathetic and other neurons in adult transgenic mice. Neuron 7: 703-716.
20. Mitchell WJ (1995). Neurons differentially control expression of a herpes simplex virus type 1 immediate-early promoter in transgenic mice. J Virol 69: 7942-7950.
21. Mitchell WJ, DeSanto R, Zhang S, Odenwald WF, Arnheiter H (1993). Herpes simplex virus pathogenesis in transgenic mice is altered by the homeodomain protein Hox 1.3. J Virol 67: 4484-4491.
22. Mitchell WJ, Gressens P, Martin JR, DeSanto R (1994). Herpes simplex virus type 1 DNA persistence, progressive disease and transgenic immediate early gene promoter activity in chronic corneal infections in mice. J Gen Virol 75: 1201-1210.
23. Mitchell WJ, Lirette RP, Fraser NW (1990). Mapping of low abundance latency-associated RNA in the trigeminal ganglia of mice latently infected with herpes simplex virus type 1. J Gen Virol 71: 125-132.
24. Perng GC, Ghiasi H, Slanina SM, Nesburn AB, Wechsler SL (1996). The spontaneous reacivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3 kilobase primary transcript. J Virol 70: 976-984.
25. Rock DL, Nesburn AB, Ghiasi H, Ong J, Lewis TL, Lokensgard JR, Wechsler SL (1987). Detection of latency-related viral RNAs intrigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J Virol 61: 3820-3826.
26. Sambrook J, Fritsch EF, Maniatis T (1989). Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
27. Stevens JG (1975). Latent herpes simplex virus and the nervous system. Curr Topic Microbiol Immunol 70: 31-50.
28. Stevens JG (1989). Human herpes viruses: a consideration of the latent state. Microbiol Rev 53: 318-332.
29. Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT (1987). RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235: 1056-1059.
30. Tal-Singer R, Lasner TM, Podrzucki W, Skokotas A, Leary JJ, Berger SL, Fraser NW (1997). Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J Virol 71: 5268-5276.
31. Tensor RB, Edris WA, Hay KA (1993). Neuronal control of herpes simplex virus latency. Virology 195: 337-347.
32. van den Pol AN, Ghosh PK (1998). Selective neuronal expression of green fluorescent protein with cytomegalovirus promoter reveals entire neuronal arbor in transgenic mice. J Neurosci 18: 10640-10651.
33. Whitley RJ (2001). Herpes simplex viruses. In: Field's virology, vol. 2. Fields BN, Knipe DM, Howley PM (eds). Philadelphia: Lippincott, Williams, & Wilkins, pp 2297-2342.
34. Zindy F, Cunningham JJ, Sherr CJ, Jogal S, Smeyne RJ, Roussel MF (1999). Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases. Proc Natl Acad Sci USA 96: 13462-13467.